Drug Approval | August 31, 2023
Strides receives USFDA approval for Mycophenolate Mofetil for oral suspension
The approval bolsters the company's Mycophenolate Mofetil portfolio
The approval bolsters the company's Mycophenolate Mofetil portfolio
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
This product will be manufactured at Lupin's Pithampur facility in India
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Subscribe To Our Newsletter & Stay Updated
